IPW
LAB icon

Impact Partnership Wealth’s Standard BioTools LAB Stock Holding History

Impact Partnership Wealth’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-192,830
Closed -$247K – 408
2025
Q4 		$247K Buy
192,830
+82,419
+75% +$111K 0.03% 304
2025
Q3 		$144K Buy
110,411
+55,667
+102% +$72.9K 0.02% 297
2025
Q2 		$65.7K Buy
54,744
+887
+2% +$983 0.01% 288
2025
Q1 		$58.2K Buy
+53,857
New +$75.6K 0.01% 256

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Impact Partnership Wealth's LAB Position: Q1 2026 in Review

Impact Partnership Wealth sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 192,830 shares — an estimated $247K sold.

Impact Partnership Wealth first reported a position in LAB in Q1 2025 and held it in 4 quarters. The position peaked at $247K in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Impact Partnership Wealth reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • Impact Partnership Wealth sold 192,830 Standard BioTools shares in Q1 2026, an estimated $247K.
  • Impact Partnership Wealth first reported a position in Standard BioTools in Q1 2025 and held it in 4 quarters.
  • Impact Partnership Wealth's Standard BioTools position peaked at $247K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.